Skip to main content

Losartan Potassium and Hydrochlorothiazide

NDC 62332-050 · Alembic Pharmaceuticals Inc.

Generic nameLosartan Potassium and Hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)LOSARTAN POTASSIUM, HYDROCHLOROTHIAZIDE
Strength25; 100 mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

62332-050-10 — 100 BLISTER PACK in 1 CARTON (62332-050-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK

62332-050-30 — 30 TABLET, FILM COATED in 1 BOTTLE (62332-050-30)

62332-050-90 — 90 TABLET, FILM COATED in 1 BOTTLE (62332-050-90)

62332-050-91 — 1000 TABLET, FILM COATED in 1 BOTTLE (62332-050-91)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

62135-669 — Quinapril and Hydrochlorothiazide, 62135-738 — Hydrochlorothiazide, 62207-741 — Losartan, 62207-742 — Losartan, 62207-743 — Losartan, 62332-027 — Losartan Potassium, 62332-028 — Losartan Potassium, 62332-029 — Losartan Potassium, 62332-048 — Losartan Potassium and Hydrochlorothiazide, 62332-049 — Losartan Potassium and Hydrochlorothiazide, 62332-051 — Irbesartan and Hydrochlorothiazide, 62332-052 — Irbesartan and Hydrochlorothiazide, 62332-053 — Irbesartan and Hydrochlorothiazide, 62332-070 — Hydrochlorothiazide, 62332-079 — Valsartan and Hydrochlorothiazide, 62332-080 — Valsartan and Hydrochlorothiazide, 62332-081 — Valsartan and Hydrochlorothiazide, 62332-082 — Valsartan and Hydrochlorothiazide, 62332-083 — Valsartan and Hydrochlorothiazide, 62332-115 — Metoprolol Tartrate and Hydrochlorothiazide, +1060 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels